1/33
Vocabulary flashcards summarizing the mechanism of action, primary therapeutic use, and key safety considerations for each drug covered in the lecture.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Baclofen
GABA-B receptor agonist that relaxes skeletal muscle for spasticity (e.g., MS, spinal injury); can cause CNS depression—taper slowly to prevent withdrawal.
Donepezil
Acetylcholinesterase inhibitor that raises brain acetylcholine to manage Alzheimer’s disease; diarrhea, insomnia, and bradycardia are common.
Interferon beta-1a
Immunomodulatory cytokine that lessens CNS inflammation in multiple sclerosis; flu-like reactions, depression, and elevated LFTs require monitoring.
Levodopa/Carbidopa
Levodopa converts to dopamine while Carbidopa blocks peripheral conversion, improving Parkinson’s symptoms; nausea and orthostatic hypotension may occur.
Memantine
NMDA receptor antagonist used in moderate-severe Alzheimer’s disease to curb excitotoxicity; dizziness and confusion possible—dose adjust in renal impairment.
Phenytoin
Voltage-gated sodium channel blocker for seizure control; gingival hyperplasia, ataxia, and rash signal toxicity—check serum levels.
Sumatriptan
5-HT1B/1D receptor agonist producing cranial vasoconstriction to abort acute migraine; chest tightness and contraindications in CVD apply.
Valproic Acid
Elevates GABA to act as broad-spectrum anticonvulsant and mood stabilizer; hepatotoxicity, weight gain, and tremor warrant LFT monitoring.
Methotrexate
Folate antagonist inhibiting DNA synthesis for RA, psoriasis, and cancers; bone-marrow suppression and hepatotoxicity necessitate CBC/LFT checks.
Raloxifene
Selective estrogen receptor modulator that preserves bone in postmenopausal osteoporosis; hot flashes and thromboembolic risk are notable.
Albuterol
Short-acting β2-adrenergic agonist providing rapid bronchodilation in asthma attacks; tremor and tachycardia are common side effects.
Alprazolam
Benzodiazepine that enhances GABA-A activity for anxiety and panic disorders; sedation and dependence potential require caution.
Amitriptyline
Tricyclic antidepressant blocking serotonin and norepinephrine reuptake, used for depression and neuropathic pain; anticholinergic effects and orthostatic hypotension seen.
Betaxolol
Selective β1-blocker lowering IOP and BP for glaucoma or hypertension; may cause bradycardia and fatigue—use cautiously in asthma.
Chlorpromazine
First-generation antipsychotic inhibiting dopamine receptors, treating schizophrenia and severe nausea; EPS, sedation, and NMS monitoring needed.
Fluoxetine
SSRI enhancing synaptic serotonin for depression, anxiety, and OCD; nausea, insomnia, and serotonin syndrome risk.
Lithium
Mood stabilizer modulating serotonin for bipolar disorder; narrow therapeutic index—tremor, polyuria, and hypothyroidism require level checks.
Pilocarpine
Muscarinic agonist stimulating secretions and lowering IOP; used for glaucoma and xerostomia, may cause sweating and bradycardia.
Timolol
Non-selective β-blocker eye drops that reduce aqueous humor for glaucoma; can induce bronchospasm or bradycardia—contraindicated in asthma.
Venlafaxine
SNRI boosting serotonin and norepinephrine to treat depression and anxiety; hypertension and insomnia warrant BP monitoring.
Acetaminophen
Central prostaglandin synthesis inhibitor used for pain and fever; overdose causes hepatotoxicity—limit to 4 g/day.
Allopurinol
Xanthine oxidase inhibitor decreasing uric acid production for gout prophylaxis; rash and hypersensitivity possible—adjust in renal impairment.
Celecoxib
Selective COX-2 inhibitor for osteoarthritis and RA pain; fewer GI ulcers but higher cardiovascular risk.
Aspirin
Irreversible COX inhibitor providing analgesia, anti-inflammation, and antiplatelet action; GI bleeding and Reye’s syndrome caution.
Morphine
Opioid μ-receptor agonist for moderate-severe pain; watch for respiratory depression, constipation, and dependence.
Naloxone
Competitive opioid antagonist reversing overdose; may precipitate withdrawal and often requires repeat dosing due to shorter half-life.
Prednisone
Systemic corticosteroid suppressing inflammation and immunity; can cause hyperglycemia, osteoporosis—must taper to prevent adrenal crisis.
Tramadol
Weak opioid and SNRI analgesic for moderate pain; lowers seizure threshold and carries serotonin syndrome risk.
Beclomethasone
Inhaled corticosteroid decreasing airway inflammation in asthma/COPD; oral thrush and hoarseness—rinse mouth post-use.
Cromolyn
Mast-cell stabilizer preventing histamine release for asthma and allergic rhinitis prophylaxis; not useful in acute attacks.
Dextromethorphan
Central antitussive suppressing cough reflex; dizziness and potential misuse at high doses—avoid alcohol.
Montelukast
Leukotriene receptor antagonist for asthma maintenance and allergic rhinitis; headache and mood changes, monitor for suicidality.
Diphenhydramine
First-generation H1 antihistamine for allergy relief and insomnia; drowsiness and anticholinergic effects, avoid in elderly fall-risk.
Codeine
Opioid agonist pro-drug providing mild-moderate analgesia and cough suppression; constipation and respiratory depression—contraindicated in children.